Works matching DE "MCNEIL Consumer Healthcare (Company)"
Results: 10
FDA advisory panel discusses droperidol concerns.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 3, p. 219, doi. 10.1093/ajhp/61.3.219
- By:
- Publication type:
- Article
New insights into root causes of pediatric accidental unsupervised ingestions of over-the-counter medications.
- Published in:
- Clinical Toxicology (15563650), 2013, v. 51, n. 10, p. 930, doi. 10.3109/15563650.2013.855314
- By:
- Publication type:
- Article
A "Phantom Recall" Does Not Comport with FDA's Regulatory Practice--Or Does It?: The Need for More Stringent Mandatory Reporting in FDA Matters.
- Published in:
- Iowa Law Review, 2012, v. 97, n. 5, p. 1839
- By:
- Publication type:
- Article
Product Update.
- Published in:
- Canadian Pharmacists Journal, 2011, v. 144, n. 1, p. 15, doi. 10.3821/1913-701X-144.1.15
- By:
- Publication type:
- Article
Children's health products recalled.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2010, v. 182, n. 9, p. E422
- By:
- Publication type:
- Article
3.0 REGULATION OF PRICE COMPETITION.
- Published in:
- Journal of Marketing, 1981, v. 45, n. 4, p. 135
- By:
- Publication type:
- Article
AFP Edition.
- Published in:
- American Family Physician, 2010, v. 81, n. 11, p. 1311
- Publication type:
- Article
McNeil Recalls More Than 500 Lots of Contaminated OTC Medications.
- Published in:
- American Family Physician, 2010, v. 81, n. 4, p. 388
- Publication type:
- Article
McNeil, Ft. Washington: FDA Case Study.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
J&J is still haunted by production problems.
- Published in:
- Chemistry & Industry, 2011, n. 1, p. 7
- By:
- Publication type:
- Article